Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanchana Ravichandran

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biochemistry|March 19, 2020
Subunit Interaction Dynamics of Class Ia Ribonucleotide Reductases: In Search of a Robust AssayKanchana Ravichandran, Lisa Olshansky, Daniel G Nocera, et al.
Nature Biotechnology|November 11, 2022
An engineered T7 RNA polymerase that produces mRNA free of immunostimulatory byproductsAthanasios Dousis, Kanchana Ravichandran, Elissa M Hobert, et al.
Scientific Reports|January 28, 2022
Therapeutic enzyme engineering using a generative neural networkAndrew Giessel, Athanasios Dousis, Kanchana Ravichandran, et al.
Biochemistry|January 20, 2017
Glutamate 350 Plays an Essential Role in Conformational Gating of Long-Range Radical Transport in Escherichia coli Class Ia Ribonucleotide ReductaseKanchana Ravichandran, Ellen C Minnihan, Qinghui Lin, et al.
Analytical Chemistry|May 28, 2019
Oligonucleotide Sequence Mapping of Large Therapeutic mRNAs via Parallel Ribonuclease Digestions and LC-MS/MSTao Jiang, Ningxi Yu, Jaeah Kim, et al.
The Journal of Biological Chemistry|April 6, 2017
Glutamate 52-β at the α/β subunit interface of <i>Escherichia coli</i> class Ia ribonucleotide reductase is essential for conformational gating of radical transferQinghui Lin, Mackenzie J Parker, Alexander T Taguchi, et al.
Elife|February 9, 2022
Ribonucleotide reductase, a novel drug target for gonorrheaJana Narasimhan, Suzanne Letinski, Stephen P Jung, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biochemistry|March 19, 2020
Subunit Interaction Dynamics of Class Ia Ribonucleotide Reductases: In Search of a Robust AssayKanchana Ravichandran, Lisa Olshansky, Daniel G Nocera, et al.
Nature Biotechnology|November 11, 2022
An engineered T7 RNA polymerase that produces mRNA free of immunostimulatory byproductsAthanasios Dousis, Kanchana Ravichandran, Elissa M Hobert, et al.
Scientific Reports|January 28, 2022
Therapeutic enzyme engineering using a generative neural networkAndrew Giessel, Athanasios Dousis, Kanchana Ravichandran, et al.
Biochemistry|January 20, 2017
Glutamate 350 Plays an Essential Role in Conformational Gating of Long-Range Radical Transport in Escherichia coli Class Ia Ribonucleotide ReductaseKanchana Ravichandran, Ellen C Minnihan, Qinghui Lin, et al.
Analytical Chemistry|May 28, 2019
Oligonucleotide Sequence Mapping of Large Therapeutic mRNAs via Parallel Ribonuclease Digestions and LC-MS/MSTao Jiang, Ningxi Yu, Jaeah Kim, et al.
The Journal of Biological Chemistry|April 6, 2017
Glutamate 52-β at the α/β subunit interface of <i>Escherichia coli</i> class Ia ribonucleotide reductase is essential for conformational gating of radical transferQinghui Lin, Mackenzie J Parker, Alexander T Taguchi, et al.
Elife|February 9, 2022
Ribonucleotide reductase, a novel drug target for gonorrheaJana Narasimhan, Suzanne Letinski, Stephen P Jung, et al.
Pageof 1